Biofrontera AG - ADR

-0.61 (-9.47%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)165.33M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$5.63
50-Day MA$5.70
200-Day MA$7.72
See more pivots

Biofrontera AG - ADR Stock, NASDAQ:BFRA

Hemmelrather Weg 201, Leverkusen, Nordrhein-Westfalen 51377
Phone: +
Number of Employees: 149


Biofrontera AG engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann L??bbert in 1997 and is headquartered in Leverkusen, Germany.